December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025 Christoph RaderChief Technology Officer at Aethon TherapeuticsSpeaker
Profile
Christoph Rader joined Aethon Therapeutics (New York, NY) as Chief Technology Officer in 2023 following an academic career as professor and principal investigator at The Scripps Research Institute in Jupiter, FL (2012-2023; acquired by the University of Florida in 2022), the National Cancer Institute (NCI) of the National Institutes of Health (NIH) in Bethesda, MD (2003-2012), and The Scripps Research Institute in La Jolla, CA (1999-2003). His labs pursued both antibody drug and target discovery for cancer therapy, with a focus on antibody display, engineering, and conjugation technologies.
Agenda Sessions
T-cell Engagers that Stabilize Drug-modified KRAS(G12C) Neoantigens Enable Selective and Potent Cross-HLA Immunotherapy
, 11:30amView Session